Cargando…

An in silico—in vitro Pipeline Identifying an HLA-A(*)02:01(+) KRAS G12V(+) Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

Targeting CD8(+) T cells to recurrent tumor-specific mutations can profoundly contribute to cancer treatment. Some of these mutations are potential tumor antigens although they can be displayed by non-spliced epitopes only in a few patients, because of the low affinity of the mutated non-spliced pep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mishto, Michele, Mansurkhodzhaev, Artem, Ying, Ge, Bitra, Aruna, Cordfunke, Robert A., Henze, Sarah, Paul, Debdas, Sidney, John, Urlaub, Henning, Neefjes, Jacques, Sette, Alessandro, Zajonc, Dirk M., Liepe, Juliane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872521/ https://www.ncbi.nlm.nih.gov/pubmed/31803176 http://dx.doi.org/10.3389/fimmu.2019.02572

Ejemplares similares

Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
por: Mishto, Michele, et al.
Publicado: (2021)

Potential Mimicry of Viral and Pancreatic β Cell Antigens Through Non-Spliced and cis-Spliced Zwitter Epitope Candidates in Type 1 Diabetes
por: Mishto, Michele, et al.
Publicado: (2021)

Proteasome-Generated cis-Spliced Peptides and Their Potential Role in CD8(+) T Cell Tolerance
por: Mansurkhodzhaev, Artem, et al.
Publicado: (2021)

Large database for the analysis and prediction of spliced and non-spliced peptide generation by proteasomes
por: Specht, Gerd, et al.
Publicado: (2020)

Database search engines and target database features impinge upon the identification of post‐translationally cis‐spliced peptides in HLA class I immunopeptidomes
por: Mishto, Michele, et al.
Publicado: (2022)

HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure
por: Khor, Seik-Soon, et al.
Publicado: (2021)

Commentary: An In Silico – In Vitro Pipeline Identifying an HLA-A*02:01(+) KRAS G12V(+) Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
por: Beer, Ilan
Publicado: (2021)

HLA-DRB1*07:01–HLA-DQA1*02:01–HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia
por: Kutszegi, Nóra, et al.
Publicado: (2017)

Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice
por: El Bissati, Kamal, et al.
Publicado: (2020)

HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02
por: Martín, Paloma, et al.
Publicado: (2015)

HLA-A*31:01 and HLA-B*15:02 as genetic markers for carbamazepine hypersensitivity in children
por: Amstutz, Ursula, et al.
Publicado: (2013)

Associations of HLA‐C*01:02 and HLA‐B*46:01 with regorafenib‐induced erythema multiforme in Japanese patients with metastatic colorectal cancer
por: Fujita, Ken‐ichi, et al.
Publicado: (2023)

Two tagging single‐nucleotide polymorphisms to capture HLA‐DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype associated with asparaginase hypersensitivity
por: Kutszegi, Nóra, et al.
Publicado: (2020)

Predicting the Success of Fmoc-Based Peptide Synthesis
por: Gutman, Ilanit, et al.
Publicado: (2022)

iBench: A ground truth approach for advanced validation of mass spectrometry identification method
por: Cormican, John A., et al.
Publicado: (2022)

Independent association of HLA-DPB1*02:01 with rheumatoid arthritis in Japanese populations
por: Furukawa, Hiroshi, et al.
Publicado: (2018)

Rapid Multiplex Genotyping of 20 HLA-A(*)02:01 Restricted Minor Histocompatibility Antigens
por: Romaniuk, Dmitrii S., et al.
Publicado: (2019)

The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule
por: Szeto, Christopher, et al.
Publicado: (2021)

Characterization of the novel HLA‐DQA1*02:01:14 allele by sequencing‐based typing
por: Cargou, Marine, et al.
Publicado: (2022)

Characterization of the novel HLA‐DPA1*02:01:21 allele by sequencing‐based typing
por: Cargou, Marine, et al.
Publicado: (2022)

inSPIRE: An Open-Source Tool for Increased Mass Spectrometry Identification Rates Using Prosit Spectral Prediction
por: Cormican, John A., et al.
Publicado: (2022)

HLA-E*01:01 + HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03 + HLA-E*01:03 genotype is associated with more severe disease
por: Hosseini, Ehteramolsadat, et al.
Publicado: (2023)

HLA-DRB1∗16:01 and HLA-DQB1∗05:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma
por: Wang, Xu, et al.
Publicado: (2021)

Protein purification and crystallization of HLA-A∗02:01 in complex with SARS-CoV-2 peptides
por: Chatzileontiadou, Demetra S.M., et al.
Publicado: (2021)

Association of HLA-A*11:01, -A*24:02, and -B*18:01 with Prostate Cancer Risk: A Case-Control Study
por: Manca, Maria Antonietta, et al.
Publicado: (2023)

Modelling Proteasome and Proteasome Regulator Activities
por: Liepe, Juliane, et al.
Publicado: (2014)

Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo
por: Teck, Anja Tatjana, et al.
Publicado: (2020)

Identification of the novel HLA‐C*07:02:01:115 allele in a volunteer bone marrow donor
por: Ulrich, Silvia, et al.
Publicado: (2021)

Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control
por: Murakoshi, Hayato, et al.
Publicado: (2018)

Quantitative time-resolved analysis reveals intricate, differential regulation of standard- and immuno-proteasomes
por: Liepe, Juliane, et al.
Publicado: (2015)

Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo
por: Teck, Anja Tatjana, et al.
Publicado: (2021)

The Associations of HLA-A*02:01 and DRB1*11:01 with Hepatitis C Virus Spontaneous Clearance Are Independent of IL28B in the Chinese Population
por: Huang, Jieting, et al.
Publicado: (2016)

Early peanut introduction wins over the HLA-DQA1*01:02 allele in the interplay between environment and genetics
por: Manohar, Monali, et al.
Publicado: (2022)

Collaboration of a Detrimental HLA-B*35:01 Allele with HLA-A*24:02 in Coevolution of HIV-1 with T Cells Leading to Poorer Clinical Outcomes
por: Kuse, Nozomi, et al.
Publicado: (2021)

An Unexpected Major Role for Proteasome-Catalyzed Peptide Splicing in Generation of T Cell Epitopes: Is There Relevance for Vaccine Development?
por: Platteel, Anouk C. M., et al.
Publicado: (2017)

A computational pipeline to generate MHC binding motifs
por: Wang, Peng, et al.
Publicado: (2011)

HLA-targeted sequencing reveals the pathogenic role of HLA-B*15:02/HLA-B*13:01 in albendazole-induced liver failure: a case report and a review of the literature
por: Liao, Jin-Mao, et al.
Publicado: (2023)

Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires
por: Scholz, Erika Margaret, et al.
Publicado: (2017)

Characterization of a novel HLA-A*11:335 allele resulting from a rare interlocus recombination involving HLA-A*11:01:01:01/126 and HLA-H*02:07/14/18 alleles with nanopore sequencing, in a volunteer from the China Marrow Donor Program
por: Zhang, Li-Qun, et al.
Publicado: (2022)

Understanding CD8(+) T-cell responses toward the native and alternate HLA-A*02:01-restricted WT1 epitope
por: Nguyen, Thi HO, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1cv3i4b4uggj6pnn41ikb2atba